Clinical Trial Update: A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin type A as headache prophylaxis for patients with frequent migraines; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• Botulinum toxin type A (OnabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-12-07